Enabling the Cure From Within
Our Expertise
Our Innovation
Our Expertise
With decades of combined experience in bioinformatics, immunology, and oncology, our team has the expertise and knowledge needed to accurately identify immunogenic mutations and target these as neoantigens
Our Vision
Our Innovation
Our Expertise
Lykeion is a clinical-stage biopharma company dedicated to the design and delivery of personalized cancer vaccines for all patients based on certain knowledge of the individual's tumor targets and natural immune response.
Our Innovation
Our Innovation
Our Innovation
We have developed a novel platform that identifies neoantigens across cancer types and a powerful vaccine approach that deploys the patient's own immunity in a broad and coordinated immune attack on their tumor